| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |